AZD1656 - Awesamo Health

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy

Animals Commercially available 8-week-old T2D mice (db/db mouse, The Jackson Laboratory homozygous BKS.Cg-Dock7m +/+ Leprdb/J, ...